Trial Profile
DOUBLE BLIND, DOUBLE DUMMY, RANDOMISED, PARALLEL GROUP, MONOCENTRIC CLINICAL TRIAL ON THE EFFECTS OF CHF 1535 MDI OR SERETIDE DPI ON LUNG HYPERINFLATION AND EXERCISE TOLERANCE IN PATIENTS WITH COPD A PILOT STUDY.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 May 2011
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol (Primary) ; Salmeterol/fluticasone propionate
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Chiesi
- 30 May 2011 New trial record